Low Dose Immunotherapy
Low dose immunotherapy (LDI) is a powerful new treatment option that drastically improves symptoms caused by infections, allergies, and sensitivities. LDI is most commonly used for chronic or recurring infections such as Lyme disease, strep, and Epstein-Barr virus (EBV), as well as food and environmental allergies, chemical sensitivities and reactions to mold toxins.
In each of these situations the issues lays in the functioning of the immune system. Our immune systems are necessary to both fight infections as well as create inflammation when it’s appropriate to do so. With allergies and chronic infections the immune systems is tipped to create inflammation beyond what is helpful for the body. The inflammation leads to chronic and sometimes debilitating symptoms, as well as takes away from the body being able to fight the pathogen.
Low dose immunotherapy is revolutionary new way to retrain the immune system to create a healthier balance. It allows the body to form a new and more appropriate response to the target substance by helping retrain a type of white blood cell called T-cells. Doing so decreases the inflammatory reaction and redirect the immune system to better fight the pathogen or become desensitized to the allergen.
Low dose immunotherapy involves the use of highly diluted substances taken orally once every 3-8 weeks until resolution of symptoms occurs. By using this treatment we often see a drastic improvement of symptoms created by addressing the underlying cause of disease.